These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31758651)

  • 1. Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis.
    Peetermans M; Meyers S; Liesenborghs L; Vanhoorelbeke K; De Meyer SF; Vandenbriele C; Lox M; Hoylaerts MF; Martinod K; Jacquemin M; Vanassche T; Verhamme P
    J Thromb Haemost; 2020 Mar; 18(3):722-731. PubMed ID: 31758651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidylarginine deiminase 4 and ADAMTS13 activity in
    Martens CP; Peetermans M; Vanassche T; Verhamme P; Jacquemin M; Martinod K
    Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20230042. PubMed ID: 37778390
    [No Abstract]   [Full Text] [Related]  

  • 3. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.
    Fukushima H; Nishio K; Asai H; Watanabe T; Seki T; Matsui H; Sugimoto M; Matsumoto M; Fujimura Y; Okuchi K
    Shock; 2013 May; 39(5):409-14. PubMed ID: 23481506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
    Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
    Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis.
    Reuken PA; Kussmann A; Kiehntopf M; Budde U; Stallmach A; Claus RA; Bruns T
    Liver Int; 2015 Jan; 35(1):37-45. PubMed ID: 25113276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress.
    Pappelbaum KI; Gorzelanny C; Grässle S; Suckau J; Laschke MW; Bischoff M; Bauer C; Schorpp-Kistner M; Weidenmaier C; Schneppenheim R; Obser T; Sinha B; Schneider SW
    Circulation; 2013 Jul; 128(1):50-9. PubMed ID: 23720451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.
    Singh K; Kwong AC; Madarati H; Kunasekaran S; Sparring T; Fox-Robichaud AE; Liaw PC; Kretz CA
    PLoS One; 2021; 16(2):e0247017. PubMed ID: 33606732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition.
    Bockmeyer CL; Reuken PA; Simon TP; Budde U; Lösche W; Bauer M; Birschmann I; Becker JU; Marx G; Claus RA
    Thromb Haemost; 2011 Jan; 105(1):145-53. PubMed ID: 21057705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
    Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
    Reiter RA; Knöbl P; Varadi K; Turecek PL
    Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure?
    Claus RA; Bockmeyer CL; Sossdorf M; Lösche W
    Curr Mol Med; 2010 Mar; 10(2):236-48. PubMed ID: 20196724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.
    Ekaney ML; Bockmeyer CL; Sossdorf M; Reuken PA; Conradi F; Schuerholz T; Blaess MF; Friedman SL; Lösche W; Bauer M; Claus RA
    Mol Med; 2015 Apr; 21(1):355-63. PubMed ID: 25860876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression of von Willebrand Factor-Binding Protein Determines Joint-Invading Capacity of Staphylococcus aureus, a Core Mechanism of Septic Arthritis.
    Na M; Hu Z; Mohammad M; Stroparo MDN; Ali A; Fei Y; Jarneborn A; Verhamme P; Schneewind O; Missiakas D; Jin T
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
    Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
    J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REVIEWING THE DYSREGULATION OF ADAMTS13 AND VWF IN SEPSIS.
    Madarati H; Singh K; Sparring T; Andrisani P; Liaw PC; Fox-Robichaud AE; Kretz CA
    Shock; 2024 Feb; 61(2):189-196. PubMed ID: 38150358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
    Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
    J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.